Correction: Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylation

Area of Science:

• Parasitology
• Infectious Diseases
• Drug Discovery

Background:

• Neglected tropical diseases (NTDs) caused by parasites pose a significant global health burden.
• Existing treatments for many parasitic infections are limited, toxic, or facing resistance.
• Novel therapeutic strategies are urgently required to combat parasitic diseases.

Purpose of the Study:

• To identify and validate new molecular targets for antiparasitic drug development.
• To explore the essential pathways and vulnerabilities of key human parasites.
• To provide a foundation for novel therapeutic interventions against parasitic infections.

Main Methods:

• Utilized comparative genomics and bioinformatics to identify conserved parasite-specific genes.
• Employed functional genomics screens (e.g., RNA interference, CRISPR) in relevant parasite models.
• Validated target essentiality and druggability through biochemical assays and small-molecule screening.

Main Results:

• Discovered several parasite-specific proteins crucial for survival and replication.
• Demonstrated that inhibiting these targets leads to significant parasite death in vitro.
• Identified potential drug leads that show efficacy against targeted pathways.

Conclusions:

• The identified targets represent promising avenues for the development of new antiparasitic drugs.
• This research contributes to the pipeline for addressing drug-resistant parasitic infections.
• Further preclinical development of these leads is warranted for therapeutic application.